Calcein-AM
Based on 88 publication(s) in Google Scholar
Calcein AM, has cell membrane permeability and can easily enter the cell. Calcein AM has no fluorescence and is hydrolyzed by endogenous esterase in the cell to produce polar molecule Calcein (Calcein), which has strong negative charge and cannot permeate the cell membrane. Calcein can emit strong green fluorescence, so it is often used with Propidium Iodide for cell viability/virulence detection, excitation/emission wavelength: 494/515 nm.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.73%
- CAS No.: 148504-34-1
- Formule: C46H46N2O23
- Masse moléculaire:994.86
-
Stockage:
-80°C, protect from light, stored under nitrogen
Publications Citing Use of MedChemExpress (MCE) Calcein-AM
More- Cancer Commun (Lond). 2024 Mar;44(3):361-383. [Abstract]
- Bioact Mater. 2022 Aug 11;21:20-31. [Abstract]
- J Extracell Vesicles. 2025 Oct;14(10):e70165. [Abstract]
- Adv Funct Mater. 2025 Sep 23.
- Adv Funct Mater. 2024 May 1.
- Nat Microbiol. 2025 Aug;10(8):2073-2091. [Abstract]
- Protein Cell. 2024 Jan 3;15(1):36-51. [Abstract]
- Nat Commun. 2025 Apr 3;16(1):3194. [Abstract]
- ACS Nano. 2023 Aug 22;17(16):15411-15423. [Abstract]
- Redox Biol. 2023 Nov:67:102923. [Abstract]
- Redox Biol. 2020 Jan;29:101402. [Abstract]
- J Nanobiotechnology. 2025 Jul 16;23(1):522. [Abstract]
- Theranostics. 2026 Apr 22;16(11):6164-6183. [Abstract]
- Acta Pharm Sin B. 2020 Sep;10(9):1694-1708. [Abstract]
- Adv Sci (Weinh). 2022 Oct;9(30):e2203031. [Abstract]
- Cell Death Differ. 2025 May 14. [Abstract]
- Cell Death Differ. 2024 Dec;31(12):1625-1635. [Abstract]
- Chem Eng J. 2024 Sep 1.
- J Control Release. 2024 Jan:365:176-192. [Abstract]
- Cancer Lett. 2025 Sep 25:634:218064. [Abstract]
- Mater Today Bio. 2025 Jan 15:31:101495. [Abstract]
- J Hazard Mater. 2025 Jul 15:492:138106. [Abstract]
- Acta Pharmacol Sin. 2023 Mar;44(3):680-692. [Abstract]
- Nano Res. 04 May 2022.
- Int J Biol Macromol. 2025 Feb 7:140739. [Abstract]
- Neural Regen Res. 2021 Sep;16(9):1813-1820. [Abstract]
- Antioxidants (Basel). 2021 May 18;10(5):798. [Abstract]
- Int J Pharm X. 2025 Oct 9:10:100413. [Abstract]
- ACS Appl Mater Interfaces. 2025 Dec 17;17(50):67595-67608. [Abstract]
- ACS Appl Mater Interfaces. 2025 Oct 1;17(39):54423-54436. [Abstract]
- Br J Cancer. 2022 Dec;127(12):2108-2117. [Abstract]
- J Environ Chem Eng. 2023 Nov 22, 111537.
- Emerg Microbes Infect. 2024 Jul 17:2382236. [Abstract]
- J Ethnopharmacol. 2021 Apr 24;270:113770. [Abstract]
- CNS Neurosci Ther. 2024 Aug;30(8):e14925. [Abstract]
- Ecotoxicol Environ Saf. 2019 Dec 30;186:109770. [Abstract]
- Cell Biosci. 2026 Jun 10. [Abstract]
- Biochem Pharmacol. 2021 Jun:188:114583. [Abstract]
- Int Endod J. 2025 Jan;58(1):111-127. [Abstract]
- Foods. 2026 Apr 21;15(8):1451. [Abstract]
- Adv Mater Technol. 2025 Dec 7.
- Int J Pharm. 2025 Apr 15:674:125483. [Abstract]
- EMBO Rep. 2019 Jul;20(7):e47563. [Abstract]
- J Funct Biomater. 2026 Apr 19;17(4):199. [Abstract]
- Colloids Surf B Biointerfaces. 2025 Dec 1:259:115337. [Abstract]
- J Diabetes. 2024 Jan;16(1):e13465. [Abstract]
- Mar Drugs. 2025 Jun 24;23(7):264. [Abstract]
- Cell Biol Toxicol. 2025 Feb 12;41(1):44. [Abstract]
- Eur J Pharmacol. 2023 Sep 5:954:175853. [Abstract]
- Pharmaceuticals. 2022 Aug 26;15(9):1059. [Abstract]
- ACS Appl Bio Mater. 2026 May 18;9(10):4617-4630. [Abstract]
- ACS Appl Bio Mater. 2026 Feb 3. [Abstract]
- ACS Appl Bio Mater. 2025 Feb 17;8(2):1065-1076. [Abstract]
- Int Immunopharmacol. 2024 Nov 4;143(Pt 3):113525. [Abstract]
- Int J Mol Sci. 2024 Oct 27;25(21):11548. [Abstract]
- Int Immunopharmacol. 2024 Jun 24:138:112518. [Abstract]
- Int J Mol Sci. 2023 Jan 11;24(2):1416. [Abstract]
- ACS Appl Bio Mater. 2021 Jan 6.
- Chem Biol Interact. 2025 Oct 8:419:111659. [Abstract]
- iScience. 2024 Feb 6;27(3):109119. [Abstract]
- Cytotherapy. 2021 Sep;23(9):810-819. [Abstract]
- Langmuir. 2025 Jan 21;41(2):1260-1270. [Abstract]
- FASEB J. 2026 Jan 31;40(2):e71439. [Abstract]
- FASEB J. 2023 Jun;37(6):e22954. [Abstract]
- Front Physiol. 2021 Jul 9;12:644903. [Abstract]
- Drug Dev Res. 2022 Aug;83(5):1176-1189. [Abstract]
- J Biomed Mater Res A. 2022 Nov;110(11):1774-1785. [Abstract]
- Micromachines. 2025 Dec 22;17(1):9.
- Cell Biol Int. 2024 Oct;48(10):1559-1572. [Abstract]
- Micromachines. 2024 Apr 18;15(4):542. [Abstract]
- Thromb Res. 2024 Nov 7:244:109210. [Abstract]
- Antibodies (Basel). 2024 Nov 20;13(4):93. [Abstract]
- Dose Response. 2019 Jul 23;17(3):1559325819865713. [Abstract]
- Biochem Biophys Res Commun. 2020 Dec 17;533(4):853-860. [Abstract]
- Biochem Biophys Res Commun. 2020 Jan 29;522(1):100-106. [Abstract]
- Oncol Lett. 2026 Mar 26;31(5):196. [Abstract]
- Res Sq. 2025 Nov 3.
- Preprints. 2025 Oct 2.
- bioRxiv. 2025 Oct 15.
- SSRN. 2025 Apr 3.
- SSRN. 2025 Jan 15.
- Research Square Preprint. 2024 Sep 10.
- Sci Total Environ. 2024 Sep 19:176358. [Abstract]
- Research Square Preprint. 2024 Mar 19.
- Research Square Preprint. 2022 Feb.
- Research Square Preprint. 2021 Feb.
- Research Square Preprint. 2021 Jan.
- Biomed Pharmacother. 2019 Sep:117:109121. [Abstract]
-
IF
-
IF
-
Cell Imaging/Staining
-
Flow Cytometry
-
IF
Activité biologique
Guide (The following is our recommended protocol. This protocol is only a guide and should be modified according to your specific needs).
1.Preparation of Calcein AM working solution
1.1 Preparation of 5 mM stock solution with DMSO.
1.2 Dilute the stock solution in serum-free cell culture medium or PBS to obtain 1-10 μM of working solution.
Note: Please adjust the concentration of Calcein AM working solution according to the actual situation.
2.Cell staining (Suspension cells: 6-well plate)
2.1 Centrifuge at 1000 g at 4°C for 3-5 minutes and then discard the supernatant. Wash twice with PBS, 5 minutes each time.
2.2 Add 1 mL of working solution, and then incubate at room temperature for 30-45 minutes.
2.3 Centrifuge at 400 g at 4°C for 3-4 minutes and then discard the supernatant.
2.4 Wash twice with PBS, 5 minutes each time.
2.5 Resuspend cells with serum-free cell culture medium or PBS. Observation by fluorescence microscopy or fluorescence microplate readers.
3. Cell staining (Adherent cells)
3.1 Culture adherent cells on sterile coverslips.
3.2 Remove the coverslip from the medium and aspirate excess medium.
3.3 Add 100 μL of working solution, gently shake it to completely cover the cells,and then incubate at room temperature for 30-45 minutes.
3.4 Wash twice with medium, 5 minutes each time. Observation by fluorescence microscopy or fluorescence microplate readers.
4. Precautions
4.1 Please adjust the concentration of Calcein AM working solution according to the actual situation.
4.2 This product is for R&D use only, not for drug, household, or other uses.
4.3 For your safety and health, please wear a lab coat and disposable gloves to operate.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
515
485
Chemical Information
-
CAS No. 148504-34-1
-
Appearance Solid
-
Masse moléculaire 994.86
-
Formule C46H46N2O23
-
Color White to off-white
-
SMILES
O=C1OC2(C(C=C(CN(CC(OCOC(C)=O)=O)CC(OCOC(C)=O)=O)C(OC(C)=O)=C3)=C3OC4=CC(OC(C)=O)=C(CN(CC(OCOC(C)=O)=O)CC(OCOC(C)=O)=O)C=C24)C5=C1C=CC=C5
-
Synonyms
Calcein acetoxymethyl ester
-
Livraison
Shipping with dry ice.
-
Stockage
-80°C, protect from light, stored under nitrogen
Publications (88)
-
Journal Impact Factor
-
Most Recent
-
Cancer Commun (Lond)
NAT10-mediated ac4C-modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear-cell renal cell carcinoma by attenuating YWHAE-driven cytoplasmic retention of YAP1. [Abstract]2024 Mar;44(3):361-383. PMID: 38407929 -
Bioact Mater
Wet adhesive hydrogel cardiac patch loaded with anti-oxidative, autophagy-regulating molecule capsules and MSCs for restoring infarcted myocardium. [Abstract]2022 Aug 11;21:20-31. PMID: 36017068
Calcein-AM purchased from MedChemExpress. Usage Cited in: Bioact Mater. 2022 Aug 11;21:20-31. [Abstract]
HUVECs proliferation is assessed by Calcein-AM, and the results show that HP-β-CD and HP-β-CD@Res could effectively promote the proliferation of HUVECs.
-
J Extracell Vesicles
3D Nanofibrillar Matrix Stiffness Modulates Extracellular Vesicle Cargo and Pro-Tumour Functions. [Abstract]2025 Oct;14(10):e70165. PMID: 41063444 -
-
-
Nat Microbiol
A single-cell transcriptomic atlas reveals senescence and inflammation in the post-tuberculosis human lung. [Abstract]2025 Aug;10(8):2073-2091. PMID: 40659921 -
Protein Cell
Human ESC-derived vascular cells promote vascular regeneration in a HIF-1α dependent manner. [Abstract]2024 Jan 3;15(1):36-51. PMID: 37158785 -
Nat Commun
Intrapleural pressure-controlled piezo-catalytic nanozyme for the inhibition of malignant pleural effusion. [Abstract]2025 Apr 3;16(1):3194. PMID: 40180981 -
ACS Nano
Antibiotic-Polymer Self-Assembled Nanocomplex to Reverse Phenotypic Resistance of Bacteria toward Last-Resort Antibiotic Colistin. [Abstract]2023 Aug 22;17(16):15411-15423. PMID: 37534992 -
Redox Biol
Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation. [Abstract]2023 Nov:67:102923. PMID: 37832398 -
Redox Biol
miR-30-5p-mediated ferroptosis of trophoblasts is implicated in the pathogenesis of preeclampsia. [Abstract]2020 Jan;29:101402. PMID: 31926626 -
J Nanobiotechnology
Exosomes derived from platelet-rich plasma alleviate synovial inflammation by enhancing synovial lymphatic function. [Abstract]2025 Jul 16;23(1):522. PMID: 40671121 -
Theranostics
Dual ROS modulation by MnO2-integrated collagen hydrogel enhances hiPSC-derived endothelial progenitor cell therapy for critical limb ischemia. [Abstract]2026 Apr 22;16(11):6164-6183. PMID: 42094610 -
Acta Pharm Sin B
Identification of bioactive anti-angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics. [Abstract]2020 Sep;10(9):1694-1708. PMID: 33088689
Calcein-AM purchased from MedChemExpress. Usage Cited in: Acta Pharm Sin B. 2020 Sep;10(9):1694-1708. [Abstract]
HUVECs were pre-treated with SMI or Rd for 24 h and seeded on Matrigel for 5.5 h followed by 0.5 h of Calcein-AM staining.
-
Adv Sci (Weinh)
Engineering Alendronate-Composed Iron Nanochelator for Efficient Peritoneal Carcinomatosis Treatment. [Abstract]2022 Oct;9(30):e2203031. PMID: 36057999
Calcein-AM purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2022 Oct;9(30):e2203031. [Abstract]
XPS analysis of CaALN powder before and after immersing in FeCl3 solution for 24 h. Detection of intracellular Fe concentration using Calcein-AM in MGC 803 cells after treatment with NaALN, CaALN, and DFX at 25 mg/L for 24 h by FCM analysis. Then these cells are washed with PBS and incubated with Calcein-AM (0.5 μM) for 15 min at 37 °C in the dark.
-
Cell Death Differ
ARID1A loss enhances sensitivity to c-MET inhibition by dual targeting of GPX4 and iron homeostasis, inducing ferroptosis. [Abstract]2025 May 14. PMID: 40369167 -
Cell Death Differ
2024 Dec;31(12):1625-1635. PMID: 39406919 -
-
J Control Release
Biofunctional coacervate-based artificial protocells with membrane-like and cytoplasm-like structures for the treatment of persistent hyperuricemia. [Abstract]2024 Jan:365:176-192. PMID: 37992873 -
Cancer Lett
Tumor-derived CCL5 recruits CCR1+ macrophages to suppress apoptosis and drive proliferation in duodenal adenocarcinoma. [Abstract]2025 Sep 25:634:218064. PMID: 41015267 -
Mater Today Bio
Okra juice used for rapid wound healing through its bioadhesive and antioxidant capabilities. [Abstract]2025 Jan 15:31:101495. PMID: 39896277 -
J Hazard Mater
Coaxially fabricated electrospinning near-infrared light-responsive nanofibrous membranes for combating drug-resistant bacteria. [Abstract]2025 Jul 15:492:138106. PMID: 40199072 -
Acta Pharmacol Sin
A high-throughput screening campaign against PFKFB3 identified potential inhibitors with novel scaffolds. [Abstract]2023 Mar;44(3):680-692. PMID: 36114272 -
-
Int J Biol Macromol
A novel antibody against GPIbα inhibits platelet function and thrombosis without increasing bleeding. [Abstract]2025 Feb 7:140739. PMID: 39924011 -
Neural Regen Res
2021 Sep;16(9):1813-1820. PMID: 33510088 -
Antioxidants (Basel)
Caffeic Acid Phenyl Ester (CAPE) Protects against Iron-Mediated Cellular DNA Damage through Its Strong Iron-Binding Ability and High Lipophilicity. [Abstract]2021 May 18;10(5):798. PMID: 34069954
Calcein-AM purchased from MedChemExpress. Usage Cited in: Antioxidants (Basel). 2021 May 18;10(5):798. [Abstract]
HeLa cells were pretreated with 20 μM Fe(II) for 2 h and then incubated with Calcein-AM (0.5 μM). After 15 min, cells were washed and incubated with or without CAPE and its analogues for 15 min. The fluorescence intensity of cells was measured by flow cytometry.
-
Int J Pharm X
2025 Oct 9:10:100413. PMID: 41142964 -
ACS Appl Mater Interfaces
Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer Treatment. [Abstract]2025 Dec 17;17(50):67595-67608. PMID: 41348354 -
ACS Appl Mater Interfaces
Recombinant Trichosanthin-Loaded Nanoparticles with Tumor-Targeting and Cell-Penetrating Capabilities for Activatable Antitumor Therapy. [Abstract]2025 Oct 1;17(39):54423-54436. PMID: 40985241 -
Br J Cancer
Corynoxine suppresses pancreatic cancer growth primarily via ROS-p38 mediated cytostatic effects. [Abstract]2022 Dec;127(12):2108-2117. PMID: 36229578 -
-
Emerg Microbes Infect
Treponema pallidum protein Tp0136 promotes angiogenesis to facilitate the dissemination of Treponema pallidum. [Abstract]2024 Jul 17:2382236. PMID: 39017656 -
J Ethnopharmacol
Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy. [Abstract]2021 Apr 24;270:113770. PMID: 33388426 -
CNS Neurosci Ther
Myelin endocytosis by brain endothelial cells causes endothelial iron overload and oligodendroglial iron hunger in hypoperfusion-induced white matter injury. [Abstract]2024 Aug;30(8):e14925. PMID: 39161089 -
Ecotoxicol Environ Saf
Evaluation of in vitro toxicity of silica nanoparticles (NPs) to lung cells: Influence of cell types and pulmonary surfactant component DPPC. [Abstract]2019 Dec 30;186:109770. PMID: 31606643 -
Cell Biosci
ERO1L induces macrophage infiltration to potentiate KrasG12D and inflammation-induced pancreatic tumorigenesis via oxidative protein folding of CCL2. [Abstract]2026 Jun 10. PMID: 42271507 -
Biochem Pharmacol
A protein-fragment complementation assay reveals that celastrol and gambogic acid suppress ERα mutants in breast cancer. [Abstract]2021 Jun:188:114583. PMID: 33915156
Calcein-AM purchased from MedChemExpress. Usage Cited in: Biochem Pharmacol. 2021 Jun:188:114583. [Abstract]
Cells were incubated with fluorescence probes Calcein-AM (1 μM) and propidium iodide (5 μM) for 5 min and imaged through a fluorescence inverted microscope.
-
Int Endod J
2025 Jan;58(1):111-127. PMID: 39257034 -
Foods
Mechanistic and Structural Analysis of Aflatoxin B1 Degradation by Bacillus safensis Multicopper Oxidase. [Abstract]2026 Apr 21;15(8):1451. PMID: 42073338 -
-
Int J Pharm
CD44-targeted nanoparticles for remodeling the tumor microenvironment in a 3D macrophage-embedded ovarian cancer model with stem cell-like features. [Abstract]2025 Apr 15:674:125483. PMID: 40101874 -
EMBO Rep
2019 Jul;20(7):e47563. PMID: 31267712
Calcein-AM purchased from MedChemExpress. Usage Cited in: EMBO Rep. 2019 Jul;20(7):e47563. [Abstract]
Cells were trypsinized, washed twice with 0.5 ml PBS, and then incubated with 0.2 μM Calcein‐AM at 37°C for 15 min. Then, the cells were washed twice with 0.5 ml PBS and either incubated with 100 μM Deferiprone or left untreated at 37°C for 1 h. The cells were analyzed with a flow cytometer. Calcein-AM was excited at 488 nm, and fluorescence was measured at 525 nm.
-
J Funct Biomater
ATP-Responsive Bimetallic Metal-Organic Frameworks Amplify Oxidative Stress in the Tumor Microenvironment for Synergistic Chemo-Immunotherapy. [Abstract]2026 Apr 19;17(4):199. PMID: 42042305 -
Colloids Surf B Biointerfaces
Enhanced separation performance and biocompatibility of polyethersulfone hollow fiber membranes using titanium diboride derived nanomaterial and gel coating for biomedical applications. [Abstract]2025 Dec 1:259:115337. PMID: 41352161 -
J Diabetes
IFN-γ enhances the therapeutic efficacy of MSCs-derived exosome via miR-126-3p in diabetic wound healing by targeting SPRED1. [Abstract]2024 Jan;16(1):e13465. PMID: 37646268 -
Mar Drugs
Lipotrichaibol A and Trichoderpeptides A-D: Five New Peptaibiotics from a Sponge-Derived Trichoderma sp. GXIMD 01001. [Abstract]2025 Jun 24;23(7):264. PMID: 40710489 -
Cell Biol Toxicol
Enhancing cardiac repair post-myocardial infarction: a study on GATM/Gel hydrogel therapeutics. [Abstract]2025 Feb 12;41(1):44. PMID: 39937362 -
Eur J Pharmacol
Isoorientin reverses lung cancer drug resistance by promoting ferroptosis via the SIRT6/Nrf2/GPX4 signaling pathway. [Abstract]2023 Sep 5:954:175853. PMID: 37329975 -
Pharmaceuticals
2022 Aug 26;15(9):1059. PMID: 36145280
Calcein-AM purchased from MedChemExpress. Usage Cited in: Pharmaceuticals. 2022 Aug 26;15(9):1059. [Abstract]
For U251 cells, Calcein-AM (10 μM) solution and 0.5 μL PI staining solution (15 μM) were added into each well and stained for 10 min.
-
ACS Appl Bio Mater
2026 May 18;9(10):4617-4630. PMID: 42089366 -
ACS Appl Bio Mater
Enhanced Dual Functionality of Pluronic F127-Blended Poly(ether sulfone) Hollow Fiber Membranes for Improved Separation and Cell Adhesion in Extracorporeal Bioartificial Kidney and Liver Applications. [Abstract]2026 Feb 3. PMID: 41630578 -
ACS Appl Bio Mater
Titanium Dioxide (TiO2) Incorporation into Poly(ether sulfone) (PES) Hollow Fiber Membranes (HFMs) Improves Biocompatibility and Separation Performance for Bioartificial Kidney (BAK) and Hemodialysis Applications. [Abstract]2025 Feb 17;8(2):1065-1076. PMID: 39843993 -
Int Immunopharmacol
Histone methylation regulates neutrophil extracellular traps to attenuate corneal neovascularization. [Abstract]2024 Nov 4;143(Pt 3):113525. PMID: 39500081 -
Int J Mol Sci
Platelet Glycoprotein Ibα Cytoplasmic Tail Exacerbates Thrombosis During Bacterial Sepsis. [Abstract]2024 Oct 27;25(21):11548. PMID: 39519103 -
Int Immunopharmacol
Targeting lipid peroxidation-associated ferroptosis suppresses lung carcinoma progression by regulating cell cycle arrest. [Abstract]2024 Jun 24:138:112518. PMID: 38917528 -
Int J Mol Sci
Trichosanthin Promotes Anti-Tumor Immunity through Mediating Chemokines and Granzyme B Secretion in Hepatocellular Carcinoma. [Abstract]2023 Jan 11;24(2):1416. PMID: 36674931 -
-
Chem Biol Interact
Standard in vitro co-culture conditions for studying inter-organ interactions between liver, breast cancer, and heart models. [Abstract]2025 Oct 8:419:111659. PMID: 40651753 -
iScience
Dendritic cells overcome Cre/Lox induced gene deficiency by siphoning cytosolic material from surrounding cells. [Abstract]2024 Feb 6;27(3):109119. PMID: 38384841 -
Cytotherapy
Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells. [Abstract]2021 Sep;23(9):810-819. PMID: 34244079 -
Langmuir
2025 Jan 21;41(2):1260-1270. PMID: 39772538 -
FASEB J
Anti-TP0136 Antibody Delayed Syphilis Wound Healing by Inhibiting Angiogenesis Through the VEGF-A Signaling Pathway: A Novel View in Nonhealing Syphilis Wounds. [Abstract]2026 Jan 31;40(2):e71439. PMID: 41524220 -
FASEB J
Artesunate protects against ocular fibrosis by suppressing fibroblast activation and inducing mitochondria-dependent ferroptosis. [Abstract]2023 Jun;37(6):e22954. PMID: 37159329 -
Front Physiol
AT1R Regulates Macrophage Polarization Through YAP and Regulates Aortic Dissection Incidence. [Abstract]2021 Jul 9;12:644903. PMID: 34305627 -
Drug Dev Res
Xanthatin inhibits non-small cell lung cancer proliferation by breaking the redox balance. [Abstract]2022 Aug;83(5):1176-1189. PMID: 35466412 -
J Biomed Mater Res A
2022 Nov;110(11):1774-1785. PMID: 35836355 -
-
Cell Biol Int
2024 Oct;48(10):1559-1572. PMID: 38953242 -
Micromachines
Precision Phenotypic Profiling and Capture of Circulating Tumor Cells via a Vertical Laminar Flow-Stacked Microfluidic Chip. [Abstract]2024 Apr 18;15(4):542. PMID: 38675353 -
Thromb Res
The role of protein kinase C and the glycoprotein Ibα cytoplasmic tail in anti-glycoprotein Ibα antibody-induced platelet apoptosis and thrombocytopenia. [Abstract]2024 Nov 7:244:109210. PMID: 39541612 -
Antibodies (Basel)
Generation, Characterization, and Preclinical Studies of a Novel NKG2A-Targeted Antibody BRY805 for Cancer Immunotherapy. [Abstract]2024 Nov 20;13(4):93. PMID: 39584993 -
Dose Response
Influence of 3-Hydroxyflavone on Colloidal Stability and Internationalization of Ag Nanomaterials Into THP-1 Macrophages. [Abstract]2019 Jul 23;17(3):1559325819865713. PMID: 31384242 -
Biochem Biophys Res Commun
Pivalopril improves anti-cancer efficiency of cDDP in breast cancer through inhibiting proliferation, angiogenesis and metastasis. [Abstract]2020 Dec 17;533(4):853-860. PMID: 33008601 -
Biochem Biophys Res Commun
Effects of cyclic fluid stress at different frequencies on behaviors of cells incubated on titanium alloy. [Abstract]2020 Jan 29;522(1):100-106. PMID: 31740003 -
Oncol Lett
2026 Mar 26;31(5):196. PMID: 41947899 -
-
-
-
-
-
-
Sci Total Environ
The impact of wastewater treatment plants on the composition and toxicity of pollutants in urban rivers in Nanjing, China. [Abstract]2024 Sep 19:176358. PMID: 39306123 -
-
-
-
-
Biomed Pharmacother
HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation. [Abstract]2019 Sep:117:109121. PMID: 31252265
Solvant et solubilité
DMSO : 100 mg/mL (100.52 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocole
K562, Daudi, and Chang liver cells are labeled with calcein-AM. Calcein-AM's excitation and emission wavelengths are 496 nm and 520 nm, respectively. The filter/mirror combination used to detect calcein-AM's green fluorescence includes the 490-nm excitation and 520-nm emission filters with a dichroic mirror. Differences in the automatic fluorescence readings between the test and control wells determine the results[1]. A simple and sensitive cell-cell adhesion microplate assay is established using the calcein-AM. The procedure involves three steps: the labeling of lymphocytes with an adequate concentration of calcein-AM (20 μM) during a short incubation period (30 min); the adhesion of 2×105 labeled lymphocytes per well to confluent keratinocyte or fibroblast monolayers grown in microtiter plates for 90 min; and, finally, measurement of the fluorescent signal utilizing a new system of cold-light microfluorimetry[2]. Cells are incubated for 15 min in 1 mL of a 1% saponin solution in PBS buffer, pH 7.4, containing 0.05% sodium azide. After saponin permeabilization, 4×105 RBCs in suspension in PBS buffer containing 0.1% saponin and 0.05% sodium azide are incubated (37°C in the dark for 45 min) with calcein-AM to a final concentration of 5 μM, ished three times with the same PBS buffer containing 0.1% saponin and 0.05% sodium azide, and the cell viability is analyzed by flow cytometry[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Pureté et documentation
-
Fiche technique (282 KB)
-
SDS (392 KB)
- English - EN (392 KB)
- Français - FR (392 KB)
- Deutsch - DE (392 KB)
- Norwegian - NO (392 KB)
- Español - ES (392 KB)
- Swedish - SV (392 KB)
- Italian - IT (392 KB)
- Korean - KR (392 KB)
- Portuguese - PT (392 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Holló Z, et al. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim Biophys Acta. 1994 May 11;1191(2):384-8. [Content Brief]
[2]. Wang XM, et al. A new microcellular cytotoxicity test based on calcein-AM release. Hum Immunol. 1993 Aug;37(4):264-70. [Content Brief]
[3]. Braut-Boucher F, et al. A non-isotopic, highly sensitive, fluorimetric, cell-cell adhesion microplate assay using calceinAM-labeled lymphocytes. J Immunol Methods. 1995 Jan 13;178(1):41-51. [Content Brief]
[4]. Bratosin D, et al. Novel fluorescence assay using calcein-AM for the determination of human erythrocyte viabilityand aging. Cytometry A. 2005 Jul;66(1):78-84. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.0052 mL | 5.0258 mL | 10.0517 mL | 25.1292 mL |
| 5 mM | 0.2010 mL | 1.0052 mL | 2.0103 mL | 5.0258 mL | |
| 10 mM | 0.1005 mL | 0.5026 mL | 1.0052 mL | 2.5129 mL | |
| 15 mM | 0.0670 mL | 0.3351 mL | 0.6701 mL | 1.6753 mL | |
| 20 mM | 0.0503 mL | 0.2513 mL | 0.5026 mL | 1.2565 mL | |
| 25 mM | 0.0402 mL | 0.2010 mL | 0.4021 mL | 1.0052 mL | |
| 30 mM | 0.0335 mL | 0.1675 mL | 0.3351 mL | 0.8376 mL | |
| 40 mM | 0.0251 mL | 0.1256 mL | 0.2513 mL | 0.6282 mL | |
| 50 mM | 0.0201 mL | 0.1005 mL | 0.2010 mL | 0.5026 mL | |
| 60 mM | 0.0168 mL | 0.0838 mL | 0.1675 mL | 0.4188 mL | |
| 80 mM | 0.0126 mL | 0.0628 mL | 0.1256 mL | 0.3141 mL | |
| 100 mM | 0.0101 mL | 0.0503 mL | 0.1005 mL | 0.2513 mL |